Does TRICARE Cover GLP-1 Medications?
“Does TRICARE cover it?” is the wrong question for a weight-loss GLP-1. The honest question is which TRICARE plan you have and why the drug is prescribed - because a covered prior authorization on the weight-loss side still leaves you paying the full price. Here is the current picture and what actually saves military families money.
Weight-loss GLP-1s (Wegovy, Zepbound, Saxenda): coverage by plan
| Plan | Weight-loss GLP-1? |
|---|---|
| Prime, Prime Remote, US Family Health Plan | With PA |
| Select, Young Adult, Reserve Select, Retired Reserve, CHCBP | With PA |
| TRICARE For Life | Not covered |
| Direct-care coverage / certain other groups | Not covered |
Per the official TRICARE pharmacy FAQ (updated Aug 2025): “You will pay 100% of the cost for your weight loss drugs even if you have an approved prior authorization.”
The catch: “covered” doesn't mean TRICARE pays
This is the part that surprises people. On the plans that do cover weight-loss GLP-1s, the prior authorization gets the prescription filled through the pharmacy benefit - but TRICARE itself pays nothing toward it. You are responsible for 100% of the cost. So the PA is a gatekeeper for access, not a discount. Before going through that process, it is worth pricing the cash-pay manufacturer and telehealth channels, which for a weight-loss GLP-1 are frequently cheaper than the full pharmacy price.
Diabetes GLP-1s (Ozempic, Mounjaro, Trulicity) are covered differently
When a GLP-1 is prescribed for type 2 diabetes and the clinical criteria are met, it is covered for eligible TRICARE members with diabetes coverage - with a prior authorization and medical-necessity form - and it carries ordinary TRICARE pharmacy copays, not the 100% weight-loss cost-share. This holds across plans, including TRICARE For Life. It is why the same molecule can cost a military family very different amounts depending on whether the prescription is written for diabetes or for weight management.
Prior authorization: what to expect
For a weight-loss GLP-1, TRICARE's prior authorization generally looks for:
- A documented BMI of 30+, or 27+ with a weight-related comorbidity
- Evidence of prior lifestyle modification (diet and activity changes)
- On recent versions of the form, a documented trial of older generic weight-loss medications before the GLP-1
The exact criteria and any step-therapy requirements are revised periodically, so have your provider pull the current prior authorization form from the TRICARE Formulary Search tool rather than relying on last year's requirements.
If you're on TRICARE For Life (or paying 100% anyway)
Whether you have TFL (no weight-loss coverage) or you're on a covered plan but facing the 100% cost-share, your practical options are the cash-pay channels:
- Wegovy cash-pay via NovoCare self-pay
- Zepbound cash-pay via LillyDirect self-pay vials
- Branded telehealth providers that bundle the prescriber visit
- The cheapest-GLP-1 finder to compare your exact cost per pound across channels
One caveat: manufacturer copay savings cards (Wegovy Savings Card, Zepbound Savings Card) are off-limits to anyone with government insurance, TRICARE included, under federal anti-kickback rules. The self-pay programs above are separate and open to you.
Frequently asked questions
Does TRICARE cover Wegovy and Zepbound for weight loss?
Only on some plans, and only in a limited sense. Weight-loss GLP-1s (Wegovy, Zepbound, Saxenda) are available with an approved prior authorization on TRICARE Prime, Prime Remote, the US Family Health Plan, Select, Young Adult, Reserve Select, Retired Reserve, and the Continued Health Care Benefit Program. They are NOT covered for TRICARE For Life beneficiaries (that ended August 31, 2025) or for direct-care coverage. The crucial catch: per TRICARE, you pay 100% of the cost for a weight-loss drug even when your prior authorization is approved. The PA lets you fill it through the pharmacy benefit; it does not make TRICARE pay for it.
Why did TRICARE For Life stop covering weight-loss drugs?
As of August 31, 2025, the TRICARE pharmacy benefit no longer covers weight-loss drugs for TRICARE For Life (TFL) beneficiaries when obesity is the primary diagnosis. TFL beneficiaries who take a GLP-1 for type 2 diabetes (for example Ozempic, Mounjaro, Trulicity, or Victoza) can continue that treatment - the change is specific to weight-loss (obesity) prescriptions, not diabetes prescriptions.
Are Ozempic and Mounjaro covered by TRICARE?
Yes, when prescribed for type 2 diabetes and the clinical criteria are met, GLP-1s like Ozempic, Mounjaro, Trulicity, and Victoza are covered for eligible TRICARE members with diabetes coverage, with a prior authorization and medical-necessity form. Unlike the weight-loss drugs, these carry ordinary TRICARE pharmacy copays rather than a 100% cost-share. That difference - diabetes indication vs weight-loss indication - is the single biggest factor in what you pay.
What does the prior authorization require?
TRICARE's weight-loss GLP-1 prior authorization generally asks for a documented BMI of 30+ (or 27+ with a weight-related comorbidity), evidence of prior lifestyle modification, and - on recent versions of the form - a documented trial of older, generic weight-loss medications first. The exact clinical criteria and step-therapy requirements change, so pull the current prior authorization form directly from the TRICARE Formulary Search tool before your provider fills it out.
I have TRICARE For Life and want a GLP-1 for weight loss. What are my options?
Since TFL no longer covers weight-loss GLP-1s, your realistic paths are cash-pay: manufacturer self-pay programs (NovoCare for Wegovy, LillyDirect self-pay vials for Zepbound) and branded telehealth. These are the same cash-pay channels anyone without coverage uses, and for a weight-loss GLP-1 they are often cheaper than paying 100% through the pharmacy benefit anyway. Note that manufacturer copay savings cards are separately off-limits to you - federal anti-kickback rules exclude all government insurance, including TRICARE, from those cards.
Does the new Medicare GLP-1 Bridge help TRICARE For Life beneficiaries?
Generally no. The Medicare GLP-1 Bridge (live July 1, 2026) delivers weight-loss GLP-1s at a $50 copay, but only to people with Medicare Part D pharmacy coverage. Most TFL beneficiaries get their drug coverage through the TRICARE Pharmacy program rather than a standalone Part D plan, so they are not eligible for the Bridge. If you are unsure how your drug coverage is structured, confirm with TRICARE before assuming either program applies.
Sources
Related guides
Stay ahead of every GLP-1 development
We'll email you when something actually matters: new FDA approvals (Foundayo, CagriSema, retatrutide), pricing drops at LillyDirect/NovoCare, telehealth deals, clinical trial results, FDA recalls, and insurance policy changes. ~1-2 emails/month. No filler.
Educational content only, not benefits or medical advice. TRICARE policies and prior authorization criteria change; verify your specific coverage through TRICARE and the current formulary tool before making decisions.